MATHEMATICAL MODELS OF ANTI-TNF THERAPIES AND THEIR CORRELATION WITH TUBERCULOSIS

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-04-23

• Fields of study

  Mathematics, Medicine

• Identifiers
  DOI 10.1002/9781118229019.CH5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability

  2012cited by this paper
• Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation

  2011cited by this paper
• Identification of Key Processes that Control Tumor Necrosis Factor Availability in a Tuberculosis Granuloma

  2010cited by this paper
• Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model.

  2010cited by this paper
• Phenomenological description of selected elementary chemical reaction mechanisms: An information-theoretic study

  2010cited by this paper
• Natural atomic probabilities in quantum information theory

  2010cited by this paper
• TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model.

  2010cited by this paper
• Understanding Latent Tuberculosis: A Moving Target

  2010cited by this paper
• Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.

  2010cited by this paper
• Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

  2009cited by this paper
• Phenomenological description of the transition state, and the bond breaking and bond forming processes of selected elementary chemical reactions: an information-theoretic study

  2009cited by this paper
• Infectious complications of tumor necrosis factor blockade

  2009cited by this paper
• Who benefits from granulomas, mycobacteria or host?

  2009cited by this paper
• Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection1

  2009cited by this paper
• Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model

  2009cited by this paper
• Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.

  2009cited by this paper
• A TNF- and c-Cbl-dependent FLIPS-degradation pathway and its function in Mycobacterium tuberculosis–induced macrophage apoptosis

  2009cited by this paper
• Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.

  2008cited by this paper
• Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.

  2008cited by this paper
• "The very pulse of the machine": the tuberculous granuloma in motion.

  2008cited by this paper
• Tumour necrosis factor antagonists: structure, function, and tuberculosis risks.

  2008cited by this paper
• Regulation of TNFR1 and CD95 signalling by receptor compartmentalization

  2008cited by this paper
• A methodology for performing global uncertainty and sensitivity analysis in systems biology.

  2008cited by this paper
• Survival and apoptotic pathways initiated by TNF‐α: Modeling and predictions

  2007cited by this paper
• Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis.

  2007cited by this paper
• Survival and apoptotic pathways initiated by TNF-alpha: modeling and predictions.

  2007cited by this paper
• Tumor necrosis factor and tuberculosis.

  2007cited by this paper
• Pharmacokinetics of Murine p75-Fc Fusion Protein and MP6-XT22 Anti-Murine TNF-α mAb in Mice

  2007cited by this paper
• Single TNFα trimers mediating NF-κB activation: stochastic robustness of NF-κB signaling

  2007cited by this paper
• In Water Thermal Imaging Comparison of the Alcon Legacy and AMO Sovereign Phacoemulsification Systems

  2007cited by this paper
• Pharmacokinetics of murine p75-Fc fusion protein and MP6-XT22 anti-murine TNF-alpha mAb in mice.

  2007cited by this paper
• Differences in Reactivation of Tuberculosis Induced from Anti-TNF Treatments Are Based on Bioavailability in Granulomatous Tissue

  2007cited by this paper
• Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses.

  2006cited by this paper
• Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques

  2006cited by this paper
• [Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience].

  2006cited by this paper
• Transient IκB Kinase Activity Mediates Temporal NF-κB Dynamics in Response to a Wide Range of Tumor Necrosis Factor-α Doses*

  2006cited by this paper
• Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection.

  2006cited by this paper
• Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion.

  2005cited by this paper
• TNF/TNFR family members in costimulation of T cell responses.

  2005cited by this paper
• Transient IKK activity mediates NF-κB temporal dynamics in response to a wide range of TNFα doses

  2005cited by this paper
• The Met-196 → Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-α-induced Apoptosis by Impaired NF-κB Signaling and Target Gene Expression*

  2005cited by this paper
• This information is current as Infection Mycobacterium tuberculosis Control of and Provide Acute , but Not Long-Term , Cell Migration and Granuloma Formation Transmembrane TNF Is Sufficient to Initiate

  2005cited by this paper
• Understanding the Immune Response in Tuberculosis Using Different Mathematical Models and Biological Scales

  2005cited by this paper
• The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games

  2005influential reference
• Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab.

  2005cited by this paper
• TNF-alpha neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome.

  2005cited by this paper
• Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?

  2005cited by this paper
• TNF-α neutralization in cytokine-driven diseases: a mathematical model to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome

  2005cited by this paper
• Dendritic cells and Mycobacterium tuberculosis: which is the Trojan horse?

  2005cited by this paper
• Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis.

  2005cited by this paper
• The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression.

  2005cited by this paper
• Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha.

  2005cited by this paper
• Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles.

  2004cited by this paper
• Tumor necrosis factor blockers and reactivation of latent tuberculosis.

  2004cited by this paper
• Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model.

  2004cited by this paper
• Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

  2004cited by this paper
• Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis 1

  2004cited by this paper
• Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system.

  2004cited by this paper
• Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

  2004cited by this paper
• T cell contributions to the different phases of granuloma formation.

  2004cited by this paper
• Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes.

  2004cited by this paper
• The human immune response to Mycobacterium tuberculosis in lung and lymph node.

  2004cited by this paper
• Immunology of tuberculosis and implications in vaccine development.

  2004cited by this paper
• TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection1

  2004cited by this paper
• Macrophage response to Mycobacteriumtuberculosis infection

  2004cited by this paper
• Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

  2004cited by this paper
• Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF

  2003cited by this paper
• Tumor necrosis factor signaling

  2003cited by this paper
• Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.

  2003cited by this paper
• Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection

  2003cited by this paper
• Chemokines and tuberculosis.

  2003cited by this paper
• Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis

  2003cited by this paper
• TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1

  2002cited by this paper
• Dissemination of Mycobacterium tuberculosis Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity

  2002cited by this paper
• Anti-tumour necrosis factor therapy in Crohn’s disease: where are we now?

  2002cited by this paper
• Binding and functional comparisons of two types of tumor necrosis factor antagonists.

  2002influential reference
• Biology of TACE inhibition

  2001cited by this paper
• Outside-to-Inside Signal Through the Membrane TNF-α Induces E-Selectin (CD62E) Expression on Activated Human CD4+ T Cells1

  2001cited by this paper
• Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology

  2001cited by this paper
• A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1

  2001cited by this paper
• Secreted Lymphotoxin-α Is Essential for the Control of an Intracellular Bacterial Infection

  2001cited by this paper
• Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.

  2001influential reference
• Molden: a pre- and post-processing program for molecular and electronic structures*

  2000cited by this paper
• Early events in TNFa - p55 receptor interactions–experiments with TNF dimers

  2000cited by this paper
• Shannon entropy of 1-normalized electron density

  2000cited by this paper
• Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages1

  2000cited by this paper
• Femtochemistry: Atomic-Scale Dynamics of the Chemical Bond†

  2000cited by this paper
• A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’

  1999cited by this paper
• Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.

  1999cited by this paper
• Inhibition of Receptor Internalization by Monodansylcadaverine Selectively Blocks p55 Tumor Necrosis Factor Receptor Death Domain Signaling*

  1999cited by this paper
• The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.

  1998cited by this paper
• Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis.

  1998cited by this paper
• Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand

  1998cited by this paper
• Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis

  1997cited by this paper
• The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes.

  1997cited by this paper
• ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors.

  1997cited by this paper
• Tumour necrosis factor and lymphotoxin: Molecular aspects and role in tissue‐specific autoimmunity

  1996cited by this paper
• Foundation for Fisher-information-based derivations of physical laws.

  1996cited by this paper
• Tumor necrosis factor: function, release and clearance.

  1996cited by this paper
• The tumor necrosis factor ligand and receptor families.

  1996cited by this paper

• Predictors of fever response in tuberculous meningitis: A clinical, MRI and biomarker study

  2021cites this paper
• The Role of Dimensionality in Understanding Granuloma Formation

  2018cites this paper
• A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection

  2016cites this paper
• Computational modeling of tuberculous meningitis reveals an important role for tumor necrosis factor-α.

  2013cites this paper
• NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis

  2012influential citation